resistant hypertension: current status, future challenges
Authors
abstract
resistant hypertension in adolescents is increasing in frequency and is increasingly recognized as having significant short- and long-term health consequences. it may be seen in up to 30% of all hypertensive patients cared for. adolescents with resistant hypertension are at higher cardiovascular (cv) risk due to a long history of severe hypertension complicated by other cv risk factors such as obesity. common causes of resistant hypertension include primary aldosteronism, sleep apnea, diabetes and chronic kidney disease. careful blood pressure (bp) measurement and thorough evaluation of patients with sustained bp elevation should make a possible early diagnosis of resistant hypertension. successful treatment requires identification and reversal of life-style factors contributing to treatment resistant and diagnosis and appropriate treatment of causes of hypertension. improved pharmacologic therapies may offer the potential for preventing or at least ameliorating early cv disease. this review highlights these and other important issues in the evaluation and management of adolescents with resistant hypertension and provides practical guidance to the practitioners involved in caring for such patients.
similar resources
Resistant Hypertension: Current Status, Future Challenges
Resistant hypertension in adolescents is increasing in frequency and is increasingly recognized as having significant short- and long-term health consequences. It may be seen in up to 30% of all hypertensive patients cared for. Adolescents with resistant hypertension are at higher cardiovascular (CV) risk due to a long history of severe hypertension complicated by other CV risk factors such as ...
full textDown Syndrome: Current Status, Challenges and Future Perspectives
Down syndrome (DS) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. It is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. Although the syndrome had been described thousands of years before, it was named after John Langdon Down who described ...
full textPharmacologic management of childhood hypertension: current status, future challenges.
The treatment of childhood hypertension has been hampered by several factors, including a lack of extensive scientific data regarding drug efficacy and pharmacokinetics in children, a lack of manufacturer's recommendations for the use of antihypertensive agents in children, and a lack of age-appropriate drug formulations. These problems have forced clinicians either to rely on limited data from...
full textUltrasonography: current status, challenges, and future directions
Since Ultrasonography was launched as an international peer-reviewed academic journal dedicated to medical ultrasound (US) in January 2014, it has been an honor and privilege for me to serve as the journal’s Honorary Editor [1]. The purpose of this editorial update is to provide readers with some recent information and to share my views on the journal and its future directions. During the last ...
full textGenitourinary Oncology: Current Status and Future Challenges
IntroductIon Genitourinary oncology (GU Oncology) focuses on research and treatment of urinary system cancers in both genders, as well as malignancies affecting the male sexual organs. Sites included are the kidneys, bladder, prostate, and testes. These malignancies represent approximately one fourth of all solid tumors, however, the field remains underrepresented in the basic science, epidemio...
full textdown syndrome: current status, challenges and future perspectives
down syndrome (ds) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. it is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. although the syndrome had been described thousands of years before, it was named after john langdon down who described ...
full textMy Resources
Save resource for easier access later
Journal title:
international journal of preventive medicineجلد ۲۰۱۴، شماره ۰۳، صفحات ۰-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023